The response to neoadjuvant chemoradiotherapy with 5-fluorouracil in locally advanced rectal cancer patients: a predictive proteomic signature

The response to neoadjuvant chemoradiotherapy with 5-fluorouracil in locally advanced rectal cancer patients: a predictive proteomic signature

Abstract Background Colorectal cancer is the third most common and the fourth most lethal cancer in the world. In the majority of cases, patients are diagnosed at an advanced stage or even metastatic, thus explaining the high mortality. The standard treatment for patients with locally advanced non-m...

Full description

Bibliographic Details
Main Authors: Anaïs Chauvin, Chang-Shu Wang, Sameh Geha, Perrine Garde-Granger, Alex-Ane Mathieu, Vincent Lacasse, François-Michel Boisvert
Format: Article
Language:English
Published: BMC 2018-04-01
Series:Clinical Proteomics
Subjects:
Rectal cancer
Resistance to neoadjuvant radio-chemotherapy
5-Fluorouracil
Proteomics
Mass spectrometry
Predictive biomarkers
Online Access:http://link.springer.com/article/10.1186/s12014-018-9192-2

Internet

http://link.springer.com/article/10.1186/s12014-018-9192-2

Similar Items